The topic is Emacs. Submissions should be on it. Comment threads may diverge, within reason.
GLP-1 drugs are seen as the next top-selling chronic disease treatment, with the potential to transform care the same way cholesterol-lowering statins did for patients at high risk of heart disease more than 30 years ago. The commercial potential is propelling drugmakers like Novo and Lilly to the top of the US and European markets. Investors are also eyeing Pfizer Inc.’s experimental danuglipron after a mid-stage study yielded positive results.
，这一点在wps中也有详细论述
Мир Российская Премьер-лига|20-й тур
Россияне пожаловались на дискриминацию в европейской стране02:00